The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Io Biotech Appoints Faiçal Miyara As Chief Business Officer
PUBLIC · IOBTQApr 05, 2024•about 2 years ago
Position
Chief Business Officer
Company
IO Biotech
Faiçal Miyara
Copenhagen
Description
IO Biotech has appointed Faiçal Miyara, Ph.D., as the company’s chief business officer. Dr. Miyara will be responsible for global business development activities including strategic partnerships
Company Information
Company
IO Biotech
Location
Copenhagen, Capital Region Of Denmark, Denmark
About
IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark.
IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has two lead immune modulating anti-cancer therapies targeting IDO and PD-L1 in clinical development and several compounds finalizing preclinical phase.
IO Biotech has an experienced management team within immuno-oncology fields and a world-class advisory board.
Copenhagen